EXOC6 is reported to be an important respondent gene when the effects of a combination of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) and taxanes were tested for cytotoxicity using human breast cancer cell lines (Chang et al., 2011). Here, EXOC6 is linked to breast cancer.